Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
Background: The value of aspirin for primary prevention continues to be debated. Data showing whether aspirin use for primary prevention adheres to established guidelines in real world practice are sparse.Methods: A total of 13,104 patients without cardiovascular diseases (CVD) were selected from th...
Main Authors: | Yinong Chen, Chun Yin, Qing Li, Luyao Yu, Longyang Zhu, Dayi Hu, Yihong Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.720113/full |
Similar Items
-
The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
by: Xie W, et al.
Published: (2019-09-01) -
Analysis of the Dilemma Involving Statins and Aspirin as Primary Prevention Alternatives in Cardiovascular Disease
by: Henry Sutanto
Published: (2017-10-01) -
Application of aspirin in the primary prevention of stroke
by: Zhao YANG, et al.
Published: (2015-02-01) -
Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran
by: Mohammadreza Amirsadri, et al.
Published: (2017-01-01) -
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
by: Georg Gelbenegger, et al.
Published: (2019-11-01)